← Browse by Condition
Medical Condition

dry eye

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for dry eye sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dry eye Clinical Trials

How many clinical trials are currently recruiting for dry eye?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for dry eye, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for dry eye?
dry eye research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a dry eye clinical trial?
Eligibility criteria for dry eye trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
The Hong Kong Polytechnic University 1 trial
Southern College of Optometry 1 trial
University of Miami 1 trial
University of Houston 1 trial
Peking University Third Hospital 1 trial

Recruiting Clinical Trials

NCT07175909
Recruiting
Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease
Enrollment
75 pts
Location
Hong Kong
Sponsor
The Hong Kong Polytechnic Univ...
View Trial →
NCT07113210 Phase 4
Recruiting
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
Enrollment
36 pts
Location
United States
Sponsor
Southern College of Optometry
View Trial →
NCT07413172 Phase 2
Recruiting
Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
Enrollment
20 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07173530
Recruiting
Low Level Light Therapy & Skin Pigmentation
Enrollment
40 pts
Location
United States
Sponsor
University of Houston
View Trial →
NCT05605314
Recruiting
Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
Enrollment
500 pts
Location
China
Sponsor
Peking University Third Hospit...
View Trial →

Related Conditions

dry eye disease ded (1) presbyopia (1) glasses (1) eye diseases (1) eyes dry chronic (1) meibomian gland dysfunction disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology